G1 Therapeutics Inc (GTHX)
4.31
-0.22
(-4.86%)
USD |
NASDAQ |
May 22, 16:00
4.35
+0.04
(+0.93%)
After-Hours: 20:00
G1 Therapeutics Cash from Operations (TTM): -18.18M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -18.18M |
December 31, 2023 | -38.34M |
September 30, 2023 | -56.18M |
June 30, 2023 | -66.85M |
March 31, 2023 | -119.49M |
December 31, 2022 | -128.62M |
September 30, 2022 | -132.65M |
June 30, 2022 | -145.48M |
March 31, 2022 | -143.41M |
December 31, 2021 | -132.11M |
September 30, 2021 | -128.96M |
June 30, 2021 | -91.24M |
March 31, 2021 | -83.60M |
December 31, 2020 | -83.74M |
September 30, 2020 | -82.24M |
Date | Value |
---|---|
June 30, 2020 | -111.01M |
March 31, 2020 | -105.05M |
December 31, 2019 | -99.57M |
September 30, 2019 | -90.79M |
June 30, 2019 | -82.47M |
March 31, 2019 | -77.74M |
December 31, 2018 | -74.31M |
September 30, 2018 | -67.82M |
June 30, 2018 | -64.77M |
March 31, 2018 | -59.35M |
December 31, 2017 | -50.52M |
September 30, 2017 | -44.98M |
June 30, 2017 | -36.51M |
March 31, 2017 | -29.13M |
December 31, 2016 | -25.14M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-145.48M
Minimum
Jun 2022
-18.18M
Maximum
Mar 2024
-97.00M
Average
-95.40M
Median
Cash from Operations (TTM) Benchmarks
Amicus Therapeutics Inc | -80.72M |
Geron Corp | -183.63M |
Palatin Technologies Inc | -33.74M |
Oragenics Inc | -8.246M |
TG Therapeutics Inc | 20.28M |